Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Tizanidine Hydrochloride Tablets

Approval Number

国药准字H20060644

Company四川科瑞德制药股份有限公司

Registration Date

December 18, 2019

Drug Information

Generic Name

盐酸替扎尼定片

Brand Name

凯莱通

Dosage Form

片剂

Strength

1mg（按C9H8ClN5S计）

Drug Type

化学药品

Registration Date

December 18, 2019

Company Information

Applicant Company

Company Name四川科瑞德制药股份有限公司

Company Address

四川省泸州国家高新区医药产业园

Manufacturing Company

Company Name四川科瑞德制药股份有限公司

Company Address

四川省泸州国家高新区医药产业园曲河西路8号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

盐酸替扎尼定片 - NMPA 批准文号 | MedPath